| Non-banking Financial Company activities | Loans and advances, securities trading, financial investment services. | Registered NBFC; regulatory compliance; strong market knowledge; diversified offerings. | B2B clients including companies and investors; also retail investors for securities. | Consulting and investment advisory services. | 1 | 1 | Interest income, trading profits, consultancy fees from financial and investment services. | Fee-based consultancy, interest on loans, trading margins. | Increased demand for financing and investments; expanding client base and profitable schemes. | |
| Biological Products | Investment and business interests via associate companies in biological product businesses. | Strategic associate partnerships; diversified asset base. | Primarily B2B involving associates and partners in the biotech sector. | Investment in high-growth biotech ventures. | 64 | 87 | Income from investments and profit share from associates. | Investment returns and profit sharing. | Associate company growth; sector demand for biological products. | |
| Other | Miscellaneous income from trading and incidental activities. | Flexible revenue sources complementing main segments. | Mixed clientele. | Operational efficiencies. | 1 | 1 | Operational income from various small scale activities. | Varied transaction-based. | Supplementary revenue streams supporting core business. | |
